CNBX
What one share of Cnbx Pharmaceuticals holds
Pharmaceutical Preparations
Cnbx Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-05-31; the balance sheet is as of 2026-05-31.
| Sales | $0.00 |
|---|---|
| Profit | −$0.00 |
| Cash and investments | $0.00 |
| Book value | −$0.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $0.05 | −$0.42 | — | — | — | — |
| 2024 | $0.00 | −$0.02 | — | — | — | −$0.08 |
| 2025 | $0.00 | −$0.00 | — | — | — | −$0.00 |
Common questions about Cnbx Pharmaceuticals
How much does one share of Cnbx Pharmaceuticals earn?
Over the last 12 months, Cnbx Pharmaceuticals lost $0.00 for each share.
Does Cnbx Pharmaceuticals pay a dividend?
Cnbx Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cnbx Pharmaceuticals’s book value per share?
Cnbx Pharmaceuticals’s book value is negative (−$0.00 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of May 31, 2026.
How much cash and debt does each share of Cnbx Pharmaceuticals have?
Each share of Cnbx Pharmaceuticals has $0.00 of cash and investments, as of May 31, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.